A jury found McKesson and Cencora liable for $266 million in damages to the city of Baltimore for fueling the opioid crisis.
Susman Godfrey partner Bill Carmody said the $266 million “verdict was an important step toward helping Baltimore recover so ...
Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. Nilotinib was originally approved under the brand name Tasigna; it is currently indicated for adults and pediatric ...
McKesson Corporation's ( NYSE:MCK ) stock was strong despite it releasing a soft earnings report last week. Our... The city ...
The pharmaceutical distributor has launched InspiroGene, a business unit offering logistics and other support for ...
McKesson (MCK) and Cencora (COR) ordered by a jury in Baltimore to pay $266M in damages to the city for their role in causing ...
A Baltimore jury found two drug distributors liable for contributing to the city's ongoing opioid crisis. The decision came ...
The city of Baltimore won $266 million in its lawsuit accusing top drug distributors McKesson and Cencora of fueling an ...
Zacks.com on MSN4d
McKesson (MCK) Is Considered a Good Investment by Brokers: Is That True?The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...
McKesson and AmerisourceBergen were found liable in Baltimore, ordered to pay over $266 million for their role in the opioid ...
There’s another phase to the trial — and likely appeals — after Tuesday’s verdict. The city has laid out a plan to spend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback